Delivery Order SPE2DB20D7059-SPE2DB25FQNS1
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Risperdal 0.5 mg tablets (60-count packages) with a contract value of $1,130.40. This is a firm fixed-price delivery order with an ultimate completion date of July 24, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation and represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of Risperdal 0.5 mg on August 18, 2025, with a ceiling value of $1,753.78 and firm fixed pricing. This competitively awarded, non-set-aside contract reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs. The delivery order is expected to be completed by August 19, 2025, with performance at the contractor's facility in...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,202.26 by the Defense Logistics Agency on August 15, 2025, for the supply of Risperdal 2 mg tablets (60-count packaging). This firm fixed-price, non-set-aside contract has an ultimate completion date of August 18, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery will be performed at...
- AmerisourceBergen Drug Corp was awarded a delivery order on July 29, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Risperdal 2 mg tablets (60-count) with a contract value of $19,929.37. The award is competitively awarded with no set-aside designation and is classified as a firm fixed-price delivery order. This order is performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 30, 2025. The delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Risperdal 3 mg tablets (60-count) under a firm fixed-price contract valued at $2,186.98. The delivery order was issued on August 25, 2025, with an ultimate completion date of August 26, 2025, and represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform all work at its corporate office location....
- This delivery order, awarded to AmerisourceBergen Drug Corp on July 18, 2025, procures 60 tablets of Risperdal 2 mg with a ceiling value of $4,281.44. The contract is a firm fixed-price delivery order issued by the Defense Logistics Agency's Medical Supply Chain and will be fulfilled at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 21, 2025. This award was competitively awarded with no set-aside designation and represents a...
- The Defense Logistics Agency awarded a $2,120.22 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 60 Risperdal 2 mg tablets. The delivery order was issued under an existing prime vendor contract vehicle and will be fulfilled by Amerisourcebergen from its facility located in Conshohocken, Pennsylvania. Performance is required between July 11-12, 2023. As the DLA supports military medical readiness through its pharmaceutical contracts, this delivery order for...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $1,434.33 contract is for the delivery of 60 tablets of the drug Risperdal 1 mg. The order has a completion date of January 22, 2024. This delivery order is part of AmerisourceBergen Drug Corp's existing contractual relationship with DLA Troop Support Medical to provide...
- This federal contract award is a $1,367.87 delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Risperdal 1 mg tablets, a mental health medication, to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
- This federal contract award is a delivery order with a firm fixed price valued at $1,836.79, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The contract is for the supply of 4568618256 - RISPERDAL 2 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of June 24, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical supplier of medical and pharmaceutical...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FQNS1Delivery Order
The Defense Logistics Agency awarded a $1,387.02 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Risperdal 2 mg, a pharmaceutical product used in treating psychiatric conditions. This firm fixed-price delivery order, awarded on August 20, 2025, with an ultimate completion date of August 21, 2025, is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation, indicating it was competitively awarded through open competition. This delivery order is a child contract executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs and other federal healthcare systems worldwide. The company, a major pharmaceutical distributor headquartered in Pennsylvania, holds a significant role in the Defense Logistics Agency's Medical Supply Chain, serving customers including the Defense Health Agency and U.S. Coast Guard through this flexible contracting mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/20/25 |